Misti Ushio is a Managing Director at Harris & Harris Group, Inc. Prior to joining Harris & Harris Group in 2007, Ms. Ushio worked at Merck & Co. for over 10 years in BioProcess Research & Development focused on vaccines and biologics, and was a Technology Licensing Officer at Columbia University.
Ms. Ushio currently serves on the board of Ancora Pharmaceuticals Inc. Senova Systems, Inc, AgBiome, LLC and OpGen, Inc. Her past investments include BioVex, Inc. (acquired by Amgen).
Ms. Ushio also serves on the board of the FastForward Accelerator at Johns Hopkins University and is on the Executive Oversight Committee for the Columbia University Coulter Foundation Grant.
She was graduated from Johns Hopkins University (B.S., Chemical Engineering), Lehigh University (M.S., Chemical Engineering) and University College London (Ph.D., Biochemical Engineering).